| | | | Index Performance | | Index | Sensex | Nifty | | Open | 15,768.28 | 4,593.10 | | High | 15,812.27 | 4,624.30 | | Low | 15,654.40 | 4,570.80 | | Today's Cls | 15,776.31 | 4,619.80 | | Prev Cls | 15,699.33 | 4,588.70 | | Change | 76.98 | 31.10 | | % Change | 0.49 | 0.68 | | | | Market Indicators | | Top Movers (Group A) | | Company | Price
(Rs) | %
chg | | Gainers | | Alok Industries | 64.05 | 10.81 | | Ranbaxy | 373.40 | 9.49 | | Housing Development | 621.75 | 7.18 | | Asahi India | 107.95 | 5.99 | | i-Gate Global | 254.30 | 5.61 | | Losers | | Suzlon Energy | 1,298.75 | -7.36 | | PNB | 525.05 | -5.00 | | ACC | 1,021.65 | -4.56 | | Chennai Petroleum | 284.45 | -3.49 | | IndusInd Bank | 52.55 | -3.49 | | | Market Statistics | | - | BSE | NSE | | Advances | 1,533 | 651 | | Declines | 1,058 | 435 | | Unchanged | 68 | 39 | | Volume(Nos) | 34.61cr | 58.05cr | | | | | | Market Commentary | | | Sensex recovers on late buying | | Sustained buying in IT and pharma stocks saw the Sensex gain 77 points at the close. | | The market resumed in the green despite weak Asian cues and rallied sharply led by capital goods and auto stocks. | | | | Energy majors Reliance Industries and ONGC also supported indices. The Sensex came of its high as profit selling began in mid-morning trades and slipped into the red as investor confidence waned. The index majors ACC and Bharti Airtel led the slump and the Sensex touched the intra-day low of 15,654. The market remained subdued thereafter but recovered on a hectic buying in heavyweights, IT and pharma stocks towards the close. The Sensex finally wrapped up the session with the gains of 77 points at 15,776. The Nifty closed 31 points up at 4,620. | | | Movers & Shakers | - Elder Pharma moved up after acquiring 20% strategic stake in Neutra Health PLC, an AIM listed company in the United Kingdom.
- Aventis Pharma gained on signing Themis Lab for technology transfer agreement for fixed - dose combinations comprising glibenclamide and glimepiride.
| | | |
The breadth of the market was positive, with gainers outnumbering losers in the ratio of 1.42:1. Of the 2,657 stocks traded on the BSE 1,533 stocks advanced, 1,058 stocks declined and 68 stocks ended unchanged. Among the sectoral indices the BSE IT Index flared up by 1.92%, the BSE Realty Index rose 1.54%, the BSE Oil & Gas Index and the BSE HC Index moved up by 1.49%. However, the BSE Bankex Index, the BSE CG Index and the BSE Metal Index closed in the red.
Among the index heavyweights, Ranbaxy was the star performer and surged 9.49% at Rs373. Cipla spurted 4.19% at Rs194, Maruti Udyog scaled up 3.88% at Rs841, Wipro soared 3.24% at Rs515, TCS advanced 3.21% at Rs1,186, Reliance Energy moved up by 2.80% at Rs780 and M&M added 2.36% at Rs801. However, ACC tumbled 4.56% at Rs1,022, Ambuja Cement slipped 2.84% at Rs125, Bharti Airtel fell 2.28% at Rs925, BHEL was down 1.93% at Rs1,755 and HDFC Bank shed 1.82% at Rs1,219. IT stocks registered significant gains. Rolta India surged 4.35% at Rs493, Mphasis soared 3.29% at Rs278, Infosys firmed up by 2.26% at Rs2,035 and HCL Technologies added 1.81% at Rs327.
Over 2.84 crore IFCI shares changed hands on the BSE followed by Manglore Chemical & Fertilizer (1.47 crore shares), Suryachakra Power Corporation (1.36 crore shares), IDFC (1.31 crore shares) and IKF Technologies (80.04 lakh shares).
HDFC was the most actively traded counter on the BSE and registered a turnover of Rs369 crore followed by IFCI (Rs160 crore), Reliance Industries (Rs153 crore), IDFC (Rs151 crore) and DLF (Rs145 crore). | | | | | | | | European Indices at 16:10 IST on 26-07-2007 | | | | Index | Level | Change (pts) | Change (%) | | FTSE 100 | 6430.80 | -23.50 | -0.36 | | CAC 40 Index | 5801.36 | -35.75 | -0.61 | | DAX Index | 7677.03 | -15.52 | -0.20 | | | | | | | | | | | Asian Indices at close on 26-07-2007 | | | | Index | Level | Change (pts) | Change (%) | | Nikkei 225 | 17702.09 | -156.33 | -0.88 | | Hang Seng | 23211.69 | -150.49 | -0.64 | | Kospi Index | 1963.54 | -40.68 | -2.03 | | Straits Times | 3579.73 | -53.81 | -1.48 | | Jakarta Composite Index | 2365.26 | -29.30 | -1.22 | | | | | | | | To know more about our products and services, click here. | | | | | | | “This document has been prepared by Sharekhan Ltd. This Document is subject to changes without prior notice and is intended only for the person or entity to which it is addressed to and may contain confidential and/or privileged material and is not for any type of circulation. Any review, retransmission, or any other use is prohibited. Kindly note that this document does not constitute an offer or solicitation for the purchase or sale of any financial instrument or as an official confirmation of any transaction.
Though disseminated to all the customers simultaneously, not all customers may receive this report at the same time. SHAREKHAN will not treat recipients as customers by virtue of their receiving this report.
The information contained herein is from publicly available data or other sources believed to be reliable. While we would endeavour to update the information herein on reasonable basis, SHAREKHAN, its subsidiaries and associated companies, their directors and employees (“SHAREKHAN and affiliates”) are under no obligation to update or keep the information current. Also, there may be regulatory, compliance, or other reasons that may prevent SHAREKHAN and affiliates from doing so. We do not represent that information contained herein is accurate or complete and it should not be relied upon as such. This document is prepared for assistance only and is not intended to be and must not alone betaken as the basis for an investment decision. The user assumes the entire risk of any use made of this information. Each recipient of this document should make such investigations as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this document (including the merits and risks involved), and should consult its own advisors to determine the merits and risks of such an investment. The investment discussed or views expressed may not be suitable for all investors. We do not undertake to advise you as to any change of our views. Affiliates of Sharekhan may have issued other reports that are inconsistent with and reach different conclusion from the information presented in this report.
This report is not directed or intended for distribution to, or use by, any person or entity who is a citizen or resident of or located in any locality, state, country or other jurisdiction, where such distribution, publication, availability or use would be contrary to law, regulation or which would subject SHAREKHAN and affiliates to any registration or licensing requirement within such jurisdiction. The securities described herein may or may not be eligible for sale in all jurisdictions or to certain category of investors. Persons in whose possession this document may come are required to inform themselves of and to observe such restriction.
SHAREKHAN & affiliates may have used the information set forth herein before publication and may have positions in, may from time to time purchase or sell or may be materially interested in any of the securities mentioned or related securities. SHAREKHAN may from time to time solicit from, or perform investment banking, or other services for, any company mentioned herein. Without limiting any of the foregoing, in no event shall SHAREKHAN, any of its affiliates or any third party involved in, or related to, computing or compiling the information have any liability for any damages of any kind. Any comments or statements made herein are those of the analyst and do not necessarily reflect those of SHAREKHAN.” | To unsubscribe write to myaccount@sharekhan.com | |
No comments:
Post a Comment